% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Knab:282566,
author = {Knab, Felix and Lee, Jun-Hoe and Nirujogi, Raja and Menden,
Kevin and Braunger, Luca and Logarnudi, Lambrianna and
Riebenbauer, Benjamin and Isik, Fatma Busra and Rajkumar,
Anto Praveen and Czemmel, Stefan and Fitzgerald, Julia and
Gasser, Thomas and Gloeckner, Christian Johannes},
title = {{C}ellular and {E}xtracellular {M}icro{RNA} {D}ysregulation
in {LRRK}2-{L}inked {P}arkinson's {D}isease.},
journal = {Molecular neurobiology},
volume = {63},
number = {1},
issn = {0893-7648},
address = {Totowa, NJ},
publisher = {Humana Press},
reportid = {DZNE-2025-01329},
pages = {189},
year = {2025},
abstract = {Cell-free microRNAs in body fluids have emerged as
promising biomarker candidates in neurodegenerative
diseases. While several studies have identified dysregulated
miRNAs in sporadic Parkinson's disease, it remains unclear
whether distinguishable alterations of cell-free miRNAs
occur in genetic forms of the disease, such as those
associated with the LRRK2 G2019S mutation. In this
proof-of-concept study, we used a human induced pluripotent
stem cell-derived dopaminergic neuron model to investigate
whether the LRRK2 G2019S mutation induces detectable changes
in the intra- and extracellular miRNAome, and whether miRNA
signatures identified in vitro can be validated in
patient-derived cerebrospinal fluid. We differentiated
dopaminergic neurons from induced pluripotent stem cells
carrying the LRRK2 G2019S mutation and an isogenic
gene-corrected control. Extracellular vesicles were isolated
from the culture medium and used as a source of cell-free
miRNA. Next, small RNA libraries were generated and
analyzed. Differentially expressed microRNAs were validated
in an independent batch using RT-qPCR. We further quantified
candidate microRNAs in cerebrospinal fluid samples from five
LRRK2 G2019S patients and matching healthy controls. The
patient cohort included the fibroblast donor from whom the
stem cells were originally derived. We successfully isolated
extracellular vesicles from induced pluripotent stem
cell-derived human dopaminergic neurons. We identified a
distinct set of differentially expressed miRNAs in cellular
and cell-free RNA, among which let-7g-5p and miR-21-5p were
consistently upregulated and validated across independent
replicates. These alterations were reflected in the
cerebrospinal fluid of the original donor and partially
reproduced in additional LRRK2 patients, supporting the
concept of patient-specific signatures. A strong correlation
between intra- and extracellular miRNA expression was
observed. Our findings demonstrate that induced pluripotent
stem cell-derived dopaminergic neurons can serve as a model
to identify individualized, cell-free microRNA signatures
associated with the LRRK2 G2019S mutation. The dysregulated
miRNAs detected in vitro were mirrored in patient
cerebrospinal fluid, supporting their potential as
accessible molecular readouts. These results lay the
groundwork for personalized biomarker strategies in genetic
forms of Parkinson's disease and warrant further validation
in larger patient cohorts.},
keywords = {Humans / Leucine-Rich Repeat Serine-Threonine Protein
Kinase-2: genetics / Leucine-Rich Repeat Serine-Threonine
Protein Kinase-2: metabolism / MicroRNAs: genetics /
MicroRNAs: metabolism / MicroRNAs: cerebrospinal fluid /
Parkinson Disease: genetics / Parkinson Disease:
cerebrospinal fluid / Induced Pluripotent Stem Cells:
metabolism / Dopaminergic Neurons: metabolism / Dopaminergic
Neurons: pathology / Extracellular Vesicles: metabolism /
Mutation: genetics / Cell Differentiation / Middle Aged /
Male / Female / Biomarker (Other) / IPSCs (Other) / LRRK2
(Other) / Micro-RNA (Other) / Parkinson’s disease (Other)
/ Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 (NLM
Chemicals) / MicroRNAs (NLM Chemicals) / LRRK2 protein,
human (NLM Chemicals)},
cin = {AG Gasser / AG Gloeckner},
ddc = {570},
cid = {I:(DE-2719)1210000 / I:(DE-2719)1210007},
pnm = {353 - Clinical and Health Care Research (POF4-353) / 352 -
Disease Mechanisms (POF4-352)},
pid = {G:(DE-HGF)POF4-353 / G:(DE-HGF)POF4-352},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41298996},
pmc = {pmc:PMC12657546},
doi = {10.1007/s12035-025-05379-2},
url = {https://pub.dzne.de/record/282566},
}